Navigation Links
Beaumont Health System Research: Accelerated Breast Radiation Treatment Provides Same Outcomes after 10 Years
Date:11/18/2013

Royal Oak, MI (PRWEB) November 18, 2013

Beaumont Hospital in Royal Oak, Mich. presented updated research results at this year’s American Society for Radiation Oncology conference. The outcomes showed that APBI, and traditional whole-breast irradiation are comparable at 10 years.

While radiation therapy has traditionally been delivered using whole breast irradiation, APBI is a proven alternative that shortens the length of treatment. The study concludes that at 10 years, there have been no differences in cancer recurring or spreading.

Anita Evans, an 87-year-old grandmother from Beverly Hills, was a participant in the study.

Evans was planning her 50th wedding anniversary celebration. She arranged for her husband, their children and grandchildren to spend an entire month in Florida. But in February 2000, during a routine physical examination, her doctor found a lump on her left breast.

“I didn’t have time for this. I’d been planning the trip for a while and arrangements had been made. I wanted to celebrate my wedding anniversary,” says Evans.

Evans was diagnosed with breast cancer, and soon after had the tumor, which was the size of a cherry pit, surgically removed. Shortly after the lumpectomy, she was referred to a radiation oncologist at Beaumont Hospital, Royal Oak who was leading a clinical trial of time-compressed radiation therapy after lumpectomy.

“At that time, Anita Evans was a perfect candidate for the five-day delivery of accelerated partial breast irradiation by brachytherapy, as opposed to whole breast irradiation delivered by the traditional six and a half weeks of external beam radiation therapy,” says Peter Chen, M.D., radiation oncologist, Beaumont, Royal Oak. “She fit the basic selection profile of an older patient greater than 50 years of age with a small tumor with no spread of cancer to the lymph nodes or elsewhere. We also wanted to try to do our best to ge
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Gulfside Dental Now Offers LUMINEERS in Beaumont, Texas
2. Gulfside Dental Celebrating Seniors Mardi Gras at Beaumont Civic Center
3. Gulfside Dental Visits First Steps Daycare in Beaumont, TX
4. Beaumont doctors call for training to reduce sudden cardiac arrest fatalities in schools
5. Beaumont Childrens Hospital pediatrician inducted into Legends of Neonatology Hall of Fame
6. Beaumont recipient of 2013 Dove Award from the Arc of Oakland County
7. Beaumont receives national green award
8. Beaumont cardiologist Kavitha Chinnaiyan, M.D., receives excellence in research award
9. Beaumont Cardiologist Kavitha Chinnaiyan, M.D., Receives Excellence in Research Award
10. Beaumont Health System Recognized as an American Heart Association Fit-Friendly Worksite
11. Beaumont Study: Nerve Stimulation Helps with Overactive Bladder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... 01, 2014 As AndroGel lawsuits and ... Ronald E. Johnson, Jr. has been appointed as co-lead ... other testosterone medications. Since the Fall of 2013, Ron ... worked diligently to investigate and prosecute the claims of ... blood clots as a result of taking testosterone. As ...
(Date:8/1/2014)... Texas (PRWEB) August 01, 2014 ... health coverage and healthcare reforms are boosting healthcare ... of medicines through discounts and increasing generic consumption ... at approximately 76.7 million in 2013, having grown ... 1.4%, from 2008. The implementation of the Health ...
(Date:8/1/2014)... 01, 2014 The "Antimicrobial Coatings ... as Zinc Oxide, Titanium Dioxide, and Zinc Omadine), ... Construction, Food & Beverages, Textiles, and others), & ... Global Trends and Forecasts to 2018" analyzes the ... opportunities, and trends in the diverse geographical regions. ...
(Date:8/1/2014)... According to new market research report "Automotive Exhaust ... & ROW), by Vehicle Type (Passenger Cars, LCVs, ... by After-Treatment Device (DPF, DOC, SCR, TWC, & ... defines and segments the global automotive exhaust systems ... all the regions, and estimates their exhaust systems ...
(Date:8/1/2014)... NY August 1, 2014 The Cardiovascular ... and first report investigations that will be presented ... scientific symposium. TCT, the world,s premier educational meeting ... September 13 17, 2014 at the Walter ... Clinical research data presented at TCT often direct ...
Breaking Medicine News(10 mins):Health News:Ron Johnson Named Co-Lead Counsel in Lawsuits for Men Injured by AndroGel and Testosterone 2Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 2Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 3Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 4Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 2Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 3Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 4Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 2Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 3Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 4Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 2Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 3Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 4
... Inc. (AIS), publisher of industry-leading newsletters Health Plan,Week, ... pleased to announce,publication of "Managed Medicare and Medicaid ... and almost 30 million Medicaid recipients,enrolled in managed ... other,companies with a stake in this market place ...
... 21 Mylan Inc. (NYSE: MYL ),today ... approval,from the U.S. Food and Drug Administration (FDA) ... Extended-release Tablets USP, 2.5,mg, 5 mg and 10 ... generic version of,AstraZeneca Pharmaceutical,s Plendil(R) Extended-release tablets, which ...
... upcoming Public Meeting on April 22, 2008, the Centers ... input for the establishment of a Healthcare Common Procedure ... II of the HCPCS is a standardized coding system ... not included in the Current Procedural Terminology (CPT) coding ...
... -- China Medicine,Corporation (OTC Bulletin Board: CHME; ... and developer of ethical and over-the-counter drugs,traditional ... devices, and medical formulations in the PRC, ... the Guangzhou Technology Bureau to represent,Guangzhou city,s ...
... Research Group survey finds that approximately 45% of physicians, intend to ... ... years, WALTHAM, Mass., April ... at the American Academy of,Orthopedic Surgeons, annual meeting in San Francisco, CA, ...
... BRIGHTON, England, April 21 Futuremedia,Learning, a leading ... Bulletin Board: FMDAY), has launched Performance Zone, a ... health,and care organisation., The launch took place ... the,UK, with Futuremedia Learning staff on-site offering support ...
Cached Medicine News:Health News:New Medicare and Medicaid Data Released: Featuring Up-To-Date Enrollment Trends, State Initiatives, Regional Market Share and Prescription Drug Benefits 2Health News:Medicare to consider public opinion about medical maggots 2Health News:Medicare to consider public opinion about medical maggots 3Health News:China Medicine Corporation Selected to Represent Biotechnology Industry of Guangzhou City at 2008 Annual BIO International Convention 2Health News:China Medicine Corporation Selected to Represent Biotechnology Industry of Guangzhou City at 2008 Annual BIO International Convention 3Health News:Physicians Anticipate Changes in Their Usage of Hip Implants 2Health News:Futuremedia Learning Launches Next Generation Learning Portal for Bupa 2
(Date:8/1/2014)... SAINT PAUL, Minn. , Aug. 1, 2014 ... leading global medical technologies company, announced today that ... a privately held manufacturer of cardiorespiratory diagnostic products ... MediSoft has served the European cardiorespiratory ... company, generated 2013 revenues of approximately €4.7 million ...
(Date:8/1/2014)...  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... study evaluating ISIS-SMN Rx in infants with spinal ... infant mortality. Isis plans to dose the first infant ... which time Isis will earn an $18 million milestone ... 3 study, ENDEAR, is the first of several planned ...
(Date:8/1/2014)... Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced ... report its second quarter 2014 financial results on Monday, ... J. Joseph Kim and CFO Peter ... corporate update, and participate in a live Q&A with ... VGX-3100, Inovio,s immune therapy targeting pre-cancers and cancers associated ...
Breaking Medicine Technology:MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 2MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 3MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 4Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 2Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 3Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 4Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 5Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 2Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 3
... collect sample, pipette into testing wells ... FDA 510K cleared multiple drug screen ... both drugs and adulterants. It can ... (5) drugs and can be accompanied ...
... Glucose Monitoring System is a patient insertable short-term ... the DexCom STS Receiver., The DexCom STS Sensor ... the DexCom STS Applicator by the user or ... held in place by an adhesive to the ...
... routine Holter,monitoring, the Burdick Vision ... a,practical, no-nonsense diagnostic tool ideal,for ... This highly accurate and,easy-to-use system ... configurations at a price even ...
... PC-based ECG diagnostics complements transition to ... the incorporation of computer-based technology into ... diagnostic instrumentation have developed. Burdick's Universal ... EMRs making it the ideal choice ...
Medicine Products: